Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities

International Journal of Cancer

Volumn 84, Issue 1, 1999, Pages 86-91

  Sarbia, Mario ^a   Stahl, Michael ^b   Fink, Ulrich ^c   Heep, Hansjörg ^a   Dutkowski, Philipp ^d   Willers, Rainhart ^a   Seeber, Siegfried ^b   Gabbert, Helmut E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLIN D1; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CELL CYCLE; DOSE RESPONSE; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLIN D1; EPIRUBICIN; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; MUCOUS MEMBRANE; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0032942806     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990219)84:1<86::AID-IJC16>3.0.CO;2-7     Document Type: Article

References (26)

1. BERENSON, J.R., KOGA, H., YANG, J., PEARL, J., HOLMES, E.C. and FIGLIN, R., Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinomas of the lung. Oncogene, 5, 1343-1348 (1990).
2. BERENSON, J.R., YANG, J. and MICKEL, R.A., Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene, 4, 1111-1116 (1989).
3. BODRUG, S.E., WARNER, B.J., BATH, M.L., LINDEMAN, G.J., HARRIS, A.W. and ADAMS, J.M., Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J., 13, 2124-2130 (1994).
4. BOSSET, J.F., GIGNOUX, M., TRIBOULET, J.P., TIRET, E., MANTION, G., ELIAS, D., LOZACH, P., OLLIER, J.C., PAVY, J.J., MERCIER, M. and SAHMOUD, S., Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N. Engl. J. Med., 337, 161-167 (1997).
5. CATTORETTI, G., BECKER, M.H.G., KEY, G., DUCHROW, M., SCHLUTER, C., GALLE, J. and GERDES, J., Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol., 168, 357-363 (1992).
6. CORDON-CARDO, C., Mutations of cell cycle regulators. Amer. J. Pathol., 147, 545-560 (1995).
7. DEISSEROTH, A.B. and DEVITA, V.T., The cell cycle-probing new molecular determinants of resistance and sensitivity to cytotoxic agents. Canter J. Sci. Amer., 1, 15-21 (1995).
8. DOWDY, S.F., HINDS, P.W., LOUIE, K., REED, S.I., ARNOLD, A. and WEINBERG, R.A., Physical interaction of the retinoblastoma protein with human cyclins. Cell. 73, 499-511 (1993).
9. GILLETT, C. RANTI, V., SMITH, R., FISHER, C., BARTEK, J., DICKSON, C., BARNES, D. and PETERS, G., Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54, 1812-1817 (1994).
10. HERMANEK, P. and SOBIN, L.H., TNM classification of malignant tumours (4th ed., 2nd rev.), Springer, Berlin (1992).
11. IKEGUCHI, M., SAITO, H., KATANO, K., TSUJITANI, S., MALTA, M. and KAIBARA, N., Clinicopathologic significance of the expression of mutated p53 protein and the proliferative activity of cancer cells in patients with esophageal squamous cell carcinoma. J. Amer. Coll. Sung. 185, 398-103 (1997).
12. JIANG, W., ZHANG, Y.J., KAHN, S.M., HOLLSTEIN, M.C., SANTELLA, R.M., LU, S.H., HARRIS, C.C., MONTESANO, R. and WEINSTEIN, I.B., Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 90, 9026-9030 (1993).
13. KATO, J., MATSUSHIME, H., HIEBERT, S.W., EWEM, M.E. and SHERR, C.J., Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Develop. 1, 331-342 (1993).
14. KELSEN, D.P., Neoadjuvant therapy for esophageal cancer. Cancer J. Sci. Amer., 3, 137-139 (1997).
15. KEYOMARSI, K. and PARDEE, R.B., Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. nat. Acad. Sci. (Wash.), 90, 1112-1116 (1993).
16. LOVEC, H., SEWING, A., LUCIBELLO, F.C., MULLER, R. and MOROY, T., Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle and malignant transformation. Oncogene, 9, 323-326 (1994).
17. NAITOH, H., SHIBATA, J., KAWAGUCHI, A., KODAMA, M. and HATTORI, T., Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Amer. J. Pathol. 146, 1161-1169 (1995).
18. NAKAGAWA, H., WANG, T.C., ODZE, R., ZUKERBERG, L., TOKAGAWA, K., MAY, G.H.W., WILSON, J. and RUSTGI, A.K., The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene, 14, 1185-1190 (1997).
19. RIMOKH, R., BERGER, F., DELSOL, G., CHARRIN, C., BERTHEAS, M.F. and FRENCH, M., Rearrangement and overexpression of the Bcl-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood, 81, 3063-3067 (1993).
20. SARBIA, M., BITTINGER, F., PORSCHEN, R., DUTKOWSKI, P., TORZEWSKI, M., WILLERS, R. and GABBERT, H.E., The prognostic significance of tumour cell proliferation in squamous cell carcinoma of the oesophagus. Brit. J. Cancer, 74, 1012-1016 (1996).
21. SHEYN, I., NOFFSINGER, A.E., HEFFELFINGER, S., DAVIS, B., MILLER, M.A. and FENOGLIO-PREISER, C.M., Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum. Pathol., 28, 270-276 (1997).
22. SHINOZAKI, H., OZAWA, S., ANDO, N., TSURUTA, H., TEREDA, M., UHDA, M. and KITAJIMA, M., Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin. Cancer Res., 2, 1155-1161 (1996).
23. STAHL, M. and 14 OTHERS, Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: interim analysis of a phase II trial. J. Clin. Oncol., 14, 829-837 (1996).
24. STRAUSS, M., LUKAS, J. and BARTER, K.J., Unrestricted cell cycling and cancer. Nature (Med.), 1, 1245-1246 (1995).
25. WORLD HEALTH ORGANIZATION, Histological typing of oesophageal and gastric tumours (2nd ed.), Springer, Berlin (1990).
26. YOUSSEF, E.M., MATSUDA, T., TAKADA, N., OSUGI, H., HIGASHINO, M., KINOSHITA, H., WATANABE, T., KATSURA, Y. WANIBUCHI, H. and FUKUSHIMA, S., Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer, 76, 358-366 (1995).